Search research articles
Contact Us
Filters
Showing results (11-20 of 236) with videos related to
Page
of 24
Sort By:
Current Opinion in Cell Biology
|
February 24, 2009
Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2
H Christian Reinhardt, Michael B Yaffe
Molecular & Cellular Oncology
|
May 28, 2019
UBQLN4 promotes non-homologous end joining by repressing DNA end-resection
Ron D Jachimowicz, H Christian Reinhardt
Frontiers in Oncology
|
November 12, 2020
Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
Yitzhak Zimmer, Hans Christian Reinhardt, Michaela Medová
Trends in Genetics : TIG
|
July 15, 2014
Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
Felix Dietlein, Lisa Thelen, H Christian Reinhardt
Cell Cycle (Georgetown, Tex.)
|
May 23, 2019
DNA double-strand break repair pathway choice - from basic biology to clinical exploitation
Ron D Jachimowicz, Jonas Goergens, H Christian Reinhardt
Cell
|
October 30, 2008
Cytokine-induced signaling networks prioritize dynamic range over signal strength
Kevin A Janes, H Christian Reinhardt, Michael B Yaffe
European Journal of Medical Research
|
June 30, 2021
Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy
Nils Mülling, Vivian Rosery, H Christian Reinhardt, et al.
Best Practice & Research. Clinical Haematology
|
October 16, 2016
Current strategies to create tailored and risk-adapted therapies for CLL patients
Paula Cramer, Barbara Eichhorst, Hans Christian Reinhardt, et al.
Leukemia & Lymphoma
|
November 23, 2019
New murine models of aggressive lymphoma
Ruth Flümann, Pascal Nieper, Hans Christian Reinhardt, et al.
Oncology Research and Treatment
|
February 19, 2016
Concepts of Chronic Lymphocytic Leukemia Pathogenesis: DNA Damage Response and Tumor Microenvironment
Lukas P Frenzel, H Christian Reinhardt, Christian P Pallasch
Page
of 24
Search research articles
Search
Showing results (11-20 of 236) with videos related to
Sort By:
Page
of 24
Current Opinion in Cell Biology
|
February 24, 2009
Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2
H Christian Reinhardt, Michael B Yaffe
Molecular & Cellular Oncology
|
May 28, 2019
UBQLN4 promotes non-homologous end joining by repressing DNA end-resection
Ron D Jachimowicz, H Christian Reinhardt
Frontiers in Oncology
|
November 12, 2020
Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
Yitzhak Zimmer, Hans Christian Reinhardt, Michaela Medová
Trends in Genetics : TIG
|
July 15, 2014
Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
Felix Dietlein, Lisa Thelen, H Christian Reinhardt
Cell Cycle (Georgetown, Tex.)
|
May 23, 2019
DNA double-strand break repair pathway choice - from basic biology to clinical exploitation
Ron D Jachimowicz, Jonas Goergens, H Christian Reinhardt
Cell
|
October 30, 2008
Cytokine-induced signaling networks prioritize dynamic range over signal strength
Kevin A Janes, H Christian Reinhardt, Michael B Yaffe
European Journal of Medical Research
|
June 30, 2021
Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy
Nils Mülling, Vivian Rosery, H Christian Reinhardt, et al.
Best Practice & Research. Clinical Haematology
|
October 16, 2016
Current strategies to create tailored and risk-adapted therapies for CLL patients
Paula Cramer, Barbara Eichhorst, Hans Christian Reinhardt, et al.
Leukemia & Lymphoma
|
November 23, 2019
New murine models of aggressive lymphoma
Ruth Flümann, Pascal Nieper, Hans Christian Reinhardt, et al.
Oncology Research and Treatment
|
February 19, 2016
Concepts of Chronic Lymphocytic Leukemia Pathogenesis: DNA Damage Response and Tumor Microenvironment
Lukas P Frenzel, H Christian Reinhardt, Christian P Pallasch
Page
of 24